- Two men accused of selling meth to undercover cop (6/22/17)
- Police: Man grabbed wheel, tried to kill driver and himself in Jackson crash (6/23/17)
- Jackson scores high in survey of residents; better streets, Aldi are high priorities (6/20/17)4
- Cape man stabbed in head, arm after strip-club incident; skull fractured, police say (6/25/17)3
- Marble Hill mayor hires city manager without board approval (6/21/17)3
- Annual SEMO District Fair event lineup announced (6/23/17)1
- Two charged in theft of jewelry from Cape storage facility (6/23/17)1
- Oran town board fired officer before hiring him as police chief; city officials say they can't remember reason for firing (6/25/17)3
- Library provides free lunches this summer (6/19/17)
- Jackson School District giving away bricks from 'Old A' building (6/23/17)2
UCLA announce first test to record Alzheimer's onset
The Associated Press
LOS ANGELES -- Researchers at the University of California at Los Angeles said Wednesday they have created the first test that records the onset of Alzheimer's disease.
The test, which identifies lesions associated with Alzheimer's in a person's brain, could improve early diagnosis and lead to more effective treatment, said Dr. Stephen Bartels, president of the American Association of Geriatric Psychiatry.
"This is a huge step forward in getting a jump on the disease before it progresses to cause brain impairment," Bartels said of the test, reported in the January issue of the American Journal of Geriatric Psychiatry.
Alzheimer's, a degenerative brain disease that causes memory loss, disorientation, depression and decay of bodily functions, affects an estimated 4 million Americans.
The disease often begins with memory lapses and advances to dementia. People with advanced cases require constant care and lose the ability to recognize even their loved ones. Among the disease's victims is former President Reagan.
The UCLA discovery means patients will be able to undergo a noninvasive test that includes a PET scan and the injection of a chemical tracer, which identifies the brain lesions linked to the disease.